{
    "title": "Eli Lilly boosts immunology business with $2.4 billion deal for Dice",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12214095/Eli-Lilly-buy-Dice-Therapeutics-2-4-billion-deal.html",
    "date": "2023-06-20",
    "keywords": [
        "psoriasis",
        "drug",
        "deal",
        "cash",
        "company",
        "tuesday",
        "pill",
        "dice",
        "trade",
        "acquisition",
        "scrutiny",
        "june",
        "co",
        "immune",
        "portfolio",
        "immunology",
        "pipeline",
        "blockbuster",
        "obesity",
        "tirzepatide",
        "mounjaro",
        "growth",
        "midstage",
        "trial",
        "condition",
        "class",
        "inflammationcausing",
        "protein",
        "interleukin17",
        "il17",
        "role",
        "mechanism",
        "injection",
        "technology",
        "platform",
        "development",
        "year",
        "share",
        "premium",
        "stock",
        "beginning",
        "quarter",
        "subject",
        "risk",
        "horizon",
        "pharma",
        "sector",
        "kind",
        "term",
        "stage",
        "size",
        "avoidant",
        "redundancy",
        "bmo",
        "analyst",
        "evan",
        "seigerman",
        "reporting",
        "leo",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}